CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 86 filers reported holding CHEMOCENTRYX INC in Q4 2017. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $558,000 | +2.2% | 60,000 | +20.0% | 0.60% | -12.0% |
| Q4 2018 | $546,000 | -52.0% | 50,000 | -44.4% | 0.68% | -43.3% |
| Q3 2018 | $1,138,000 | +1.7% | 90,000 | +5.9% | 1.21% | +6.8% |
| Q2 2018 | $1,119,000 | +9.7% | 85,000 | +13.3% | 1.13% | -7.7% |
| Q1 2018 | $1,020,000 | +7.1% | 75,000 | -53.1% | 1.23% | +2.4% |
| Q4 2017 | $952,000 | -19.8% | 160,000 | 0.0% | 1.20% | -3.9% |
| Q3 2017 | $1,187,000 | -20.8% | 160,000 | 0.0% | 1.24% | -17.2% |
| Q2 2017 | $1,498,000 | +28.6% | 160,000 | 0.0% | 1.50% | +27.6% |
| Q1 2017 | $1,165,000 | +31.2% | 160,000 | +33.3% | 1.18% | +17.4% |
| Q4 2016 | $888,000 | +63.2% | 120,000 | +33.3% | 1.00% | +71.5% |
| Q3 2016 | $544,000 | -19.3% | 90,000 | -40.0% | 0.58% | -24.1% |
| Q2 2016 | $674,000 | – | 150,000 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |